In T2DM and CAD patients, CTRP9 is positively correlated with BMI, glucose metabolism parameters, inflammatory markers, and adhesion molecules, and is negatively correlated with adiponectin. The gene discussed is C1QTNF9; the disease is coronary artery disorder.